Top News

Questcor Pharmaceuticals Buys BioVectra




QuestCor Pharmaceuticals, the Anaheim-based biopharmaceuticals firm providing treatments for autoimmune and inflammatory disorders, said yetserday that it has acquired BioVectra, a supplier of contract manufacturing services to the pharmaceuticals and biotechnology industry. The deal was worth approximately $50.7M (C$50M). BioVectra has been Questcor's manufacturing partner for nearly a decade, and is based in Prince Edward Island, Canada.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel